MyFinsight
Home
Blog
About
Back
Income Statement
GALECTIN THERAPEUTICS INC (GALT)
GALECTIN THERAPEUTICS INC (GALT)
source: myfinsight.com
Net loss applicable
to common...
-$9,175K
(-20.98%↓ Y/Y)
Net loss
-$9,113K
(-21.17%↓ Y/Y)
Preferred stock dividends
$62K
(-1.59%↓ Y/Y)
Total other income
(expense)
-$5,131K
(-77.18%↓ Y/Y)
Total operating loss
-$3,982K
(13.90%↑ Y/Y)
Interest income
$28K
(7.69%↑ Y/Y)
Change in fair value of
derivative
-$3,155K
(-187.86%↓ Y/Y)
Interest expense
$2,004K
(9.75%↑ Y/Y)
Total operating
expenses
$3,982K
(-13.90%↓ Y/Y)
Research and development
$2,135K
(-34.53%↓ Y/Y)
General and
administrative
$1,847K
(35.41%↑ Y/Y)
Back